Company intelligence / Profile preview
Kuros Biosciences
Schlieren, Switzerlandkurosbio.com ↗
- Ownership
- Public · KURN
- Employees
- ~101
- Development stage
- Commercial
01
Overview
Kuros Biosciences has established itself as a leader in next-generation bone healing technologies. Its flagship product line, MagnetOs synthetic bone grafts, has been used in over 10,000 spinal fusion surgeries across three continents with strong real-world results. Recent Level I studies show high fusion rates even in high-risk patients. The company’s pipeline includes the first drug-biologic combination for interbody spinal fusions (Fibrin-PTH) currently in Phase 2 trials. In FY2024 the company achieved record revenue growth (+125% YoY), positive EBITDA for the first time, and continued global expansion[3][7][8].
- Therapeutic areas
- RheumatologyNeurology
- Modalities
- Synthetic bone grafts (e.g., MagnetOs)Drug-biologic combination products (e.g., Fibrin-PTH)Medical sealants
- Industry
- Biotech
02
Drug pipeline
13 assets12 more assets in the full pipeline.
03
Partnerships
Medtronic Spinal Division – exclusive strategic agreementdistribution agreements with top spine companies[1]
04
Financials
- Market cap
- $973.9M
- Total revenue
- $148.3M
- Enterprise value
- $977.8M
Beyond the preview
Go deeper on Kuros Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kuros Biosciences.